A detailed history of Israel Englander (Millennium Management LLC) transactions in Tekla Life Sciences Investors stock. As of the latest transaction made, Millennium Management LLC holds 13,560 shares of HQL stock, worth $193,908. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,560
Previous 18,197 25.48%
Holding current value
$193,908
Previous $257,000 20.62%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$14.26 - $15.78 $66,123 - $73,171
-4,637 Reduced 25.48%
13,560 $204,000
Q1 2024

May 15, 2024

SELL
$13.38 - $14.33 $213,424 - $228,577
-15,951 Reduced 46.71%
18,197 $248,000
Q4 2023

Feb 14, 2024

BUY
$11.35 - $13.6 $264,670 - $317,138
23,319 Added 215.34%
34,148 $459,000
Q2 2023

Aug 14, 2023

BUY
$13.13 - $14.17 $142,184 - $153,446
10,829 New
10,829 $146,000
Q4 2022

Feb 14, 2023

BUY
$13.55 - $15.23 $192,084 - $215,900
14,176 Added 40.25%
49,394 $702,000
Q3 2022

Nov 14, 2022

BUY
$13.39 - $16.31 $471,569 - $574,405
35,218 New
35,218 $481,000
Q1 2020

May 14, 2020

SELL
$12.22 - $17.99 $225,080 - $331,357
-18,419 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$14.63 - $17.84 $56,969 - $69,468
3,894 Added 26.81%
18,419 $321,000
Q3 2019

Nov 14, 2019

BUY
$15.09 - $17.09 $219,182 - $248,232
14,525 New
14,525 $219,000
Q2 2019

Aug 14, 2019

SELL
$15.54 - $17.47 $256,207 - $288,027
-16,487 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$15.5 - $17.9 $13,206 - $15,250
852 Added 5.45%
16,487 $282,000
Q4 2018

Feb 14, 2019

BUY
$13.99 - $20.35 $218,733 - $318,172
15,635 New
15,635 $236,000
Q3 2018

Nov 14, 2018

SELL
$18.89 - $20.49 $210,189 - $227,992
-11,127 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$18.13 - $19.4 $201,732 - $215,863
11,127 New
11,127 $209,000

Others Institutions Holding HQL

About TEKLA LIFE SCIENCES INVESTORS


  • Ticker HQL
  • Exchange NYSE
  • Sector Financial Services
  • Industry Asset Management
  • Description
  • Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...
More about HQL
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.